HCA Healthcare, Inc. $HCA Shares Sold by iA Global Asset Management Inc.

iA Global Asset Management Inc. trimmed its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 42,821 shares of the company’s stock after selling 2,243 shares during the period. iA Global Asset Management Inc.’s holdings in HCA Healthcare were worth $19,991,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of the stock. May Hill Capital LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth approximately $220,000. Qsemble Capital Management LP acquired a new position in shares of HCA Healthcare during the 4th quarter worth approximately $3,342,000. AlphaCore Capital LLC raised its position in shares of HCA Healthcare by 12.2% during the 4th quarter. AlphaCore Capital LLC now owns 792 shares of the company’s stock worth $370,000 after purchasing an additional 86 shares during the last quarter. Convergence Investment Partners LLC raised its position in shares of HCA Healthcare by 385.1% during the 4th quarter. Convergence Investment Partners LLC now owns 2,954 shares of the company’s stock worth $1,379,000 after purchasing an additional 2,345 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. raised its position in shares of HCA Healthcare by 4,545.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock worth $309,686,000 after purchasing an additional 649,058 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Down 2.3%

Shares of NYSE HCA opened at $422.68 on Friday. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52. The firm has a fifty day moving average of $478.74 and a 200-day moving average of $485.84. The stock has a market capitalization of $93.77 billion, a PE ratio of 14.54, a P/E/G ratio of 1.34 and a beta of 1.18.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. During the same period in the prior year, the firm earned $6.45 earnings per share. The firm’s quarterly revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is 10.73%.

Insiders Place Their Bets

In related news, EVP Michael R. Mcalevey sold 1,694 shares of the company’s stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the sale, the executive vice president directly owned 8,853 shares of the company’s stock, valued at approximately $4,721,924.61. This represents a 16.06% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.50% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on HCA shares. Leerink Partners cut their price target on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Mizuho boosted their price target on HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a report on Wednesday, February 25th. Stephens cut their price target on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a report on Monday, April 27th. Barclays cut their price target on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a report on Monday, April 27th. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $525.00 price target on shares of HCA Healthcare in a report on Friday, April 24th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $517.82.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.